186 related articles for article (PubMed ID: 24835058)
1. Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis.
Garg T; Pinheiro LC; Atoria CL; Donat SM; Weissman JS; Herr HW; Elkin EB
J Urol; 2014 Oct; 192(4):1072-7. PubMed ID: 24835058
[TBL] [Abstract][Full Text] [Related]
2. Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities.
Richards KA; Ham S; Cohn JA; Steinberg GD
Int J Urol; 2016 Jan; 23(1):42-7. PubMed ID: 26443388
[TBL] [Abstract][Full Text] [Related]
3. Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation.
Cohn JA; Vekhter B; Lyttle C; Steinberg GD; Large MC
Cancer; 2014 Feb; 120(4):555-61. PubMed ID: 24496869
[TBL] [Abstract][Full Text] [Related]
4. Variation in the Diagnostic Evaluation among Persons with Hematuria: Influence of Gender, Race and Risk Factors for Bladder Cancer.
Ark JT; Alvarez JR; Koyama T; Bassett JC; Blot WJ; Mumma MT; Resnick MJ; You C; Penson DF; Barocas DA
J Urol; 2017 Nov; 198(5):1033-1038. PubMed ID: 28655530
[TBL] [Abstract][Full Text] [Related]
5. Sex and the Diagnostic Pathway to Bladder Cancer among Veterans: No Evidence of Disparity.
Lynch KE; Viernes B; Khader K; DuVall SL; Schroeck FR
Womens Health Issues; 2020; 30(2):128-135. PubMed ID: 31870696
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of gender-based disparities in time from initial haematuria presentation to upper tract urothelial carcinoma diagnosis: analysis of a nationwide insurance claims database.
Chappidi MR; Kates M; Tosoian JJ; Johnson MH; Hahn NM; Bivalacqua TJ; Pierorazio PM
BJU Int; 2017 Sep; 120(3):377-386. PubMed ID: 28418183
[TBL] [Abstract][Full Text] [Related]
7. Predictors of delay to cystoscopy and adequacy of investigations in patients with haematuria.
Ngo B; Papa N; Perera M; Bolton D; Sengupta S
BJU Int; 2017 May; 119 Suppl 5():19-25. PubMed ID: 28544302
[TBL] [Abstract][Full Text] [Related]
8. Geographic Variation in Cystoscopy Rates for Suspected Bladder Cancer between Female and Male Medicare Beneficiaries.
Han DS; Zhou W; Seigne JD; Lynch KE; Schroeck FR
Urology; 2018 Dec; 122():83-88. PubMed ID: 30138684
[TBL] [Abstract][Full Text] [Related]
9. Can hematuria be a predictor as well as a symptom or sign of bladder cancer?
Friedman GD; Carroll PR; Cattolica EV; Hiatt RA
Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):993-6. PubMed ID: 8959322
[TBL] [Abstract][Full Text] [Related]
10. Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer?
Henning A; Wehrberger M; Madersbacher S; Pycha A; Martini T; Comploj E; Jeschke K; Tripolt C; Rauchenwald M
BJU Int; 2013 Jul; 112(1):68-73. PubMed ID: 23320798
[TBL] [Abstract][Full Text] [Related]
11. Prospective external validation of a bladder cancer detection model.
Lotan Y; Svatek RS; Krabbe LM; Xylinas E; Klatte T; Shariat SF
J Urol; 2014 Nov; 192(5):1343-8. PubMed ID: 24859442
[TBL] [Abstract][Full Text] [Related]
12. Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer.
Cha EK; Tirsar LA; Schwentner C; Hennenlotter J; Christos PJ; Stenzl A; Mian C; Martini T; Pycha A; Shariat SF; Schmitz-Dräger BJ
World J Urol; 2012 Dec; 30(6):847-52. PubMed ID: 23124847
[TBL] [Abstract][Full Text] [Related]
13. Can reproductive characteristics predict bladder cancer in women with haematuria?
Yavuzcan A; Caglar M; Kayikci MA; Basaran E; Tekin A; Ozdemir E; Dilbaz S; Ustun Y; Cam HK
Asian Pac J Cancer Prev; 2013; 14(9):5107-10. PubMed ID: 24175784
[TBL] [Abstract][Full Text] [Related]
14. Patterns of hematuria referral to urologists: does a gender disparity exist?
Johnson EK; Daignault S; Zhang Y; Lee CT
Urology; 2008 Sep; 72(3):498-502; discussion 502-3. PubMed ID: 18619657
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Hematuria Evaluation by Advanced Practice Providers and Urologists.
Hyman MJ; Skolarus TA; Litwack K; Meltzer DO; Modi PK
Urology; 2023 Aug; 178():67-75. PubMed ID: 37196831
[TBL] [Abstract][Full Text] [Related]
16. Gender, race, and variation in the evaluation of microscopic hematuria among Medicare beneficiaries.
Bassett JC; Alvarez J; Koyama T; Resnick M; You C; Ni S; Penson DF; Barocas DA
J Gen Intern Med; 2015 Apr; 30(4):440-7. PubMed ID: 25451992
[TBL] [Abstract][Full Text] [Related]
17. Predicting bladder cancer risk in patients with hematuria. A single-centre retrospective study.
Jarimba R; Quaresma V; Pedroso Lima J; Eliseu M; Tavares da Silva E; Moreira P; Figueiredo A
Arch Ital Urol Androl; 2023 Mar; 95(1):11026. PubMed ID: 36924379
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting the timeliness and adequacy of haematuria assessment in bladder cancer: a systematic review.
Ngo B; Perera M; Papa N; Bolton D; Sengupta S
BJU Int; 2017 May; 119 Suppl 5():10-18. PubMed ID: 28544294
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Hospital-Based Hematuria Diagnosis and Subsequent Cancer Risk Among Adults in Denmark.
Nørgaard M; Veres K; Ording AG; Djurhuus JC; Jensen JB; Sørensen HT
JAMA Netw Open; 2018 Nov; 1(7):e184909. PubMed ID: 30646376
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic tests in urology: urine cytology.
Lavallée LT; Fergusson D; Dahm P; Scales CD; Witiuk K; Breau RH
BJU Int; 2012 Dec; 110(11 Pt C):E789-91. PubMed ID: 23106855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
